Average Approval Time Is Slower For Drugs, Faster For Biologics
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Average time to approval rose in 2004 to 18.7 months for NMEs, but biologics average was significantly lower at 20.2 months. 2003 averages were 17.1 for drugs, 36.9 for biologics